APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | ![](/images/1078/if_selected_60x60.jpg) | | ![](/images/1078/2858_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ARF1 | ADP-ribosylation factor 1 | | | ![](/images/7742/if_selected_60x60.jpg) | | ![](/images/7742/18909_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) | Disease related genes
| | ![](/images/26078/if_selected_60x60.jpg) | | ![](/images/26078/55901_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
ARHGAP12 | Rho GTPase activating protein 12 | | | ![](/images_static/na_center.gif) | | ![](/images/412/104313_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
ARHGAP4 | Rho GTPase activating protein 4 | | | | | ![](/images/1012/2393_A_9_3_rna_selected_60x60.jpg) | Expressed in all |
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | Cytoskeleton related proteins Plasma proteins
| | | | ![](/images/18584/43130_B_2_6_rna_selected_60x60.jpg) | Expressed in all |
ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | | | ![](/images/14658/if_selected_60x60.jpg) | | ![](/images/14658/38011_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
ARID3B | AT rich interactive domain 3B (BRIGHT-like) | Transcription factors
| | | | ![](/images/50320/115525_B_7_8_rna_selected_60x60.jpg) | Mixed |
ARL6IP5 | ADP-ribosylation-like factor 6 interacting protein 5 | Predicted membrane proteins
| | | | ![](/images/15540/34874_B_7_5_rna_selected_60x60.jpg) | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | ![](/images/4318/11330_B_1_7_rna_selected_60x60.jpg) | Expressed in all |
ASMTL | Acetylserotonin O-methyltransferase-like | | | | | ![](/images/21865/131980_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
ASNA1 | ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial) | Transporters
| | | | ![](/images/45951/103532_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | ![](/images/59303/133134_B_9_8_rna_selected_60x60.jpg) | Expressed in all |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/20896/48102_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
ATF2 | Activating transcription factor 2 | Enzymes Transcription factors
| | | | ![](/images/3769/11709_A_7_8_rna_selected_60x60.jpg) | Expressed in all |
ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/12911/29668_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | ![](/images/5605/15397_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins
| | | | ![](/images/1528/4689_A_1_5_rna_selected_60x60.jpg) | Expressed in all |
ATP5H | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d | Mitochondrial proteins
| | | | ![](/images/42777/101425_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
ATP5J | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 | Mitochondrial proteins Plasma proteins
| | | | ![](/images/31069/65266_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | ![](/images/2572/6946_B_1_6_rna_selected_60x60.jpg) | Expressed in all |
B3GAT1 | Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2500/6207_B_3_3_rna_selected_60x60.jpg) | Tissue enriched |
B4GALNT1 | Beta-1,4-N-acetyl-galactosaminyl transferase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/8968/24762_A_3_3_rna_selected_60x60.jpg) | Tissue enriched |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | ![](/images/10807/25954_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | ![](/images/19918/47053_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
BAIAP2 | BAI1-associated protein 2 | Plasma proteins
| | | | ![](/images/27421/57220_B_2_7_rna_selected_60x60.jpg) | Expressed in all |
BAIAP2L1 | BAI1-associated protein 2-like 1 | | | | | ![](/images/29503/61555_B_8_1_rna_selected_60x60.jpg) | Mixed |
BAX | BCL2-associated X protein | Cancer-related genes Mitochondrial proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/4206/13373_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
BCAP29 | B-cell receptor-associated protein 29 | Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images/49694/if_selected_60x60.jpg) | | ![](/images/29215/63696_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | ![](/images/3906/11752_A_1_6_rna_selected_60x60.jpg) | Expressed in all |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted secreted proteins
| | | | ![](/images/443/1114_B_2_5_rna_selected_60x60.jpg) | Mixed |
BCAT2 | Branched chain amino-acid transaminase 2, mitochondrial | Enzymes Mitochondrial proteins
| | ![](/images_static/na_center.gif) | | ![](/images/54091/131673_B_9_5_rna_selected_60x60.jpg) | Expressed in all |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | ![](/images/27770/57596_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
BID | BH3 interacting domain death agonist | Mitochondrial proteins
| | | | ![](/images/3771/10350_A_5_1_rna_selected_60x60.jpg) | Expressed in all |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | ![](/images/3894/12744_A_8_3_rna_selected_60x60.jpg) | Tissue enriched |
BIN2 | Bridging integrator 2 | Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/38667/106333_A_3_5_rna_selected_60x60.jpg) | Mixed |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes
| | | | ![](/images/4270/11490_A_2_8_rna_selected_60x60.jpg) | Mixed |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | ![](/images/41937/90336_B_1_6_rna_selected_60x60.jpg) | Expressed in all |
BNIP2 | BCL2/adenovirus E1B 19kDa interacting protein 2 | Predicted membrane proteins
| | ![](/images/26843/if_selected_60x60.jpg) | | ![](/images/26843/55938_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | ![](/images_static/na_center.gif) | | ![](/images/1328/3905_B_2_3_rna_selected_60x60.jpg) | Expressed in all |
BTF3 | Basic transcription factor 3 | Plasma proteins
| | | | ![](/images/56420/136162_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/1198/2772_A_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
BTRC | Beta-transducin repeat containing E3 ubiquitin protein ligase | | | ![](/images/31156/if_selected_60x60.jpg) | | ![](/images/32986/67926_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
BUB3 | BUB3 mitotic checkpoint protein | | | | | ![](/images/3601/11197_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
C14orf2 | Chromosome 14 open reading frame 2 | Mitochondrial proteins Predicted membrane proteins
| | ![](/images/60520/if_selected_60x60.jpg) | | ![](/images/58978/135195_B_7_5_rna_selected_60x60.jpg) | Expressed in all |
C1orf116 | Chromosome 1 open reading frame 116 | | | ![](/images_static/na_center.gif) | | ![](/images/11888/28062_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
C1QBP | Complement component 1, q subcomponent binding protein | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | ![](/images/26483/if_selected_60x60.jpg) | | ![](/images/26483/54897_A_9_4_rna_selected_60x60.jpg) | Expressed in all |
C20orf112 | Chromosome 20 open reading frame 112 | | | | | ![](/images/43600/99802_B_7_1_rna_selected_60x60.jpg) | Expressed in all |
C21orf33 | Chromosome 21 open reading frame 33 | Mitochondrial proteins Predicted secreted proteins
| | | | ![](/images/18517/41671_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/926/2497_B_8_8_rna_selected_60x60.jpg) | Tissue enriched |